OrthoPediatrics (KIDS) Stock Price, News & Analysis

Company Overview

OrthoPediatrics Corp. is a medical device company focused exclusively on developing and commercializing orthopedic products for children. The company designs implants, instruments and related technologies intended to address the distinct anatomical and clinical needs of pediatric patients, including those with congenital conditions, traumatic injuries and musculoskeletal disorders.

Its product portfolio covers pediatric trauma and deformity correction, scoliosis, limb reconstruction, sports medicine and other specialized orthopedic procedures. Products include systems for fracture fixation, spinal correction, guided growth, external fixation and related surgical applications, supported by instruments designed for use by pediatric orthopedic surgeons.

Founded in 2006 and headquartered in Warsaw, Indiana, OrthoPediatrics sells its products primarily through a combination of direct sales and distribution relationships. The company serves hospitals and surgeons in the United States and international markets, with a focus on expanding access to pediatric orthopedic technologies globally.

Key Stats

• Today's Range: $30.07 to $31.48
• 50-Day Range: $21.56 to $31.52
• 52-Week Range: $14.42 to $32.62
• Volume: 488,128 shs
• Average Volume: 327,747 shs
• Market Capitalization: $794.53 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $30.75
• Consensus Rating: Moderate Buy

OrthoPediatrics Stock Analysis - MarketRank™

OrthoPediatrics scored higher than 30% of companies evaluated by MarketBeat, and ranked 783rd out of 901 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.4 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

OrthoPediatrics has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on no strong buy ratings, 7 buy ratings, 1 hold rating, and 1 sell rating.

Upside/Downside

The consensus price target for OrthoPediatrics is close to its current price, suggesting limited near-term upside or downside.

Amount of Analyst Coverage

OrthoPediatrics has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for OrthoPediatrics are expected to grow in the coming year, from ($1.09) to ($0.78) per share.

Price to Book Value per Share Ratio

OrthoPediatrics has a P/B Ratio of 2.20. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

5.55% of the float of OrthoPediatrics has been sold short.

Short Interest Ratio / Days to Cover

OrthoPediatrics has a short interest ratio ("days to cover") of 4.8.

Change versus previous month

Short interest in OrthoPediatrics has recently increased by 5.09%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

OrthoPediatrics does not currently pay a dividend.

Dividend Growth

OrthoPediatrics does not have a long track record of dividend growth.

News and Social Media

• Score: 2.0 / 5
• News Sentiment: 0.22

News Sentiment

OrthoPediatrics has a news sentiment score of 0.22. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.65 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 17 news articles for OrthoPediatrics this week, compared to 2 articles on an average week.

Search Interest

Only 2 people have searched for KIDS on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days.

Company Ownership

• Score: 2.1 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, OrthoPediatrics insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $46,747,931.00 in company stock.

Percentage Held by Insiders

32.50% of the stock of OrthoPediatrics is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

69.05% of the stock of OrthoPediatrics is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 10/27/2026
• Today: 11/03/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: NASDAQ:KIDS
• CIK: 1425450
• Web: www.orthopediatrics.com
• Phone: (574) 268-6379
• Fax: 574-269-3692
• Employees: 602
• Year Founded: 2006

Price Target and Rating

• Average Price Target for OrthoPediatrics: $30.75
• High Price Target: $38.00
• Low Price Target: $27.00
• Potential Upside/Downside: +1.1%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.67
• Research Coverage: 9 Analysts

Profitability

• EPS (Trailing Twelve Months): ($1.43)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$39.65 million
• Net Margins: -12.83%
• Pretax Margin: -15.61%
• Return on Equity: -8.08%
• Return on Assets: -5.46%

Debt

• Debt-to-Equity Ratio: 0.28
• Current Ratio: 4.78
• Quick Ratio: 2.17

Sales & Book Value

• Annual Sales: $236.35 million
• Price / Sales: 3.36
• Cash Flow: $0.16 per share
• Price / Cash Flow: 185.22
• Book Value: $13.82 per share
• Price / Book: 2.20

Miscellaneous

• Outstanding Shares: 26,110,000
• Free Float: 17,624,000
• Market Cap: $794.53 million
• Optionable: Optionable
• Beta: 0.99